View on market: Stay Cautious, be with quality business:

Asian equities edged higher on the first day of a new quarter as investors assess U.S. President Joe Biden’s new plan. Equities tracked overnight gains on Wall Street. Benchmark indices in Japan and South Korea outperformed while those in Australia had more modest gains. The U.S. Dollar stabilised after posting its best quarter in a year while the treasuries held losses after its worst quarterly performance since 1980. The Singapore-traded SGX Nifty, an early indicator of the Nifty 50 Index’s performance in India, rose 0.72% to 14,852, as of 8:30 a.m.

Key Data/ Action, Result and Board meeting to watch

Major economic Data:

  • INR: Federal Fiscal Deficit (Feb) on 31th  March, 2021
  • INR: Infrastructure Output (YoY) (Feb) on 31st  March, 2021
  • USD : Pending Home Sales (MoM) (Feb) on 31th March, 2021
  • USD: Crude Oil Inventories on 31st March, 2021

International Markets:

U.S & Europe

Particulars    1st  April. Chg Chg(%)
Nasdaq 13,246.87 201.48 1.54
Dow 32981.55 -85.41 -0.26
FTSE 6,713.63 -58.49 -0.86
CAC 6,067.23 -20.81 -0.34
DAX 15,008.34 -0.27 0
Dow Fut.* 32,863.00 -35 -11


Asian markets:

Particulars       1st April. Chg Chg(%)
SGX Nifty 14,852.00 106 0.72
Nikkei 29,513.59 334.79 1.15
Straits Times 3,176.45 11.11 0.35
Hang Seng 28,609.42 231.07 0.81
Shanghai 3,453.07 11.16 0.32


   ADR Watch:

Particulars                 31th Mar.    Chg Chg(%)
Dr Reddy 61.39 0.27 0.44
HDFC Bank 77.69 -3.21 -3.97
ICICI Bank 16.03 -0.16 -0.99
Infosys 18.72 -0.08 -0.43
Tata Motor 20.79 0.27 1.32
Wipro 6.34 -0.05 -0.78


Commodities & Currency

Particulars Current Price Chg(%)
USD/INR 73.11 -0.37
Brent 62.98 0.38
Gold 173.45 -0.11
Silver 24.387 -0.59



Particulars 31st Mar 30th  Mar
FIIs -1685.91 769.47
DIIs 2081.52 2181.01


News Update:

Axis Bank:

Has entered into a share purchase agreement to sell 100% stake in Axis Bank U.K. Ltd. to OpenPayd Holdings Ltd. Sale to fetch an overall consideration of $5.5 million along with book value of the bank. Transaction likely to be completed by September 30, 2021, subject to approval from the U.K. financial regulator.


Announces acquisition of Australia-based Ampion for a cash consideration of $117 million. The transaction is expected to be completed during the quarter ending June 30, 2021. The deal is subject to regulatory approvals and customary closing conditions. Ampion is the provider of cyber security, development operations and quality engineering services in Australia.

HCL Technologies:

Has entered into an agreement with Tenneco for a multi-year, integrated application development, modernisation, and operations services contract.


Novelis Inc announced the completion of offering of €500 million aggregate principal amount of 3.375% euro-denominated senior green notes due April 15, 2029 by Novelis Sheet Ingot GmbH, an indirect wholly-owned subsidiary of Novelis. The Notes are guaranteed, jointly and severally, on a senior unsecured basis, by Novelis, and by certain Novelis subsidiaries.

Hindustan Aeronautics:

Recorded a revenue in excess of Rs 22,700 crore for the financial year ended March 31, 2021 and posted a revenue growth of around 6%. Further, the company has ended the year with a positive cash balance of around Rs 6,700 crore as against borrowings of Rs 5,775 crore as on March 31, 2020.
Likhitha Infrastructures:

The company received a contract of Rs 34.63 crore from Indian Oil Adani Gas Pvt. Ltd. on March 31, 2021 for laying Pipeline from Thrissur Geographical Area to Ernakulam Geographical Area. Post this order, the company has received orders worth Rs 234.85 crore from various oil and gas distribution companies during Q4FY21.

Rossari Biotech:

Has fully operationalised all phases of its Greenfield manufacturing facility at Dahej, Gujarat. The Greenfield facility will have a total installed capacity of 132,500 MTPA. The facility will not only provide cost and logistical advantage but also double the company’s overall capacity. Rossari is confident of ramping up utilisation levels at Dahej courtesy a strong upcoming product Pipeline

Bodal Chemicals:

Has acquired Siel Chemical Complex situated at Rajpura in Punjab from Mawana Sugars. The operations from the said unit will be merged with Bodal Chemicals from April 1, 2021.

Bank of India:

Gets capital infusion of Rs 3,000 crore from the government.

Central Bank of India:

Divestment of entire stake in Cent Bank Home Finance to Centrum Housing Finance has been cancelled. The lender has also received capital infusion of Rs 4,800 crore from the government.

Indian Overseas Bank:

Gets capital infusion of Rs 4,100 crore from the government.


Has completed the formalities for the takeover of Rangit Stage-IV HE Project (120 MW) by remitting Rs 165 crore to the account of Jal power Corporation for distribution to the creditors as per the approved resolution plan. JPCL is now a wholly-owned subsidiary of  the company.


First part capacity of 70 MW of 85 MW Bilhaur Solar PV Project in Uttar Pradesh, is declared on Commercial Operation with effect from March 28

Godrej Properties:

Has increased its stake in Godrej Realty from 51% to 100% by acquiring equity shares from HDFC Venture Trustee Company. Subsequently, Godrej Realty has become a wholly-owned subsidiary of the company with effect from March 31.

Source: MoneyControl, Business Standard, Bloomberg,Investing


Elite Wealth Limited does/does not do business with companies covered in its research reports. Investors should be aware that the Elite Wealth Limited may/may not have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only information in making their investment decision and must exercise their own judgment before making any investment decision.
For analyst certification and other important disclosures, see the Disclosure Appendix, or go to Analysts employed by Elite Wealth Limited are registered/qualified as research analysts with SEBI in India.( SEBI Registration No.: INH100002300)
Disclosure Appendix
Analyst Certification (For Reports)
Israil Khan, Elite Wealth Limited,
The analyst(s) certify that all of the views expressed in this report accurately reflect my/our personal views about the subject company or companies and its or their securities. I/We also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report. Unless otherwise stated, the individuals listed on the cover page of this report are analysts in Elite Wealth Limited.
As to each individual report referenced herein, the primary research analyst(s) named within the report individually certify, with respect to each security or issuer that the analyst covered in the report, that:
(1) all of the views expressed in the report accurately reflect his or her personal views about any and all of the subject securities or issuers; and
(2) no part of any of the research analyst’s compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed in the report. For individual analyst certifications, please refer to the disclosure section at the end of the attached individual notes.
Research Excerpts
This note may include excerpts from previously published research. For access to the full reports, including analyst certification and important disclosures, investment thesis, valuation methodology, and risks to rating and price targets, please visit
Company-Specific Disclosures
Important disclosures, including price charts, are available and all Elite Wealth Limited covered companies by visiting, or emailing with your request. Elite Wealth Limited may screen companies based on Strategy, Technical, and Quantitative Research. For important disclosures for these companies, please e-mail
Options related research:
If the information contained herein regards options related research, such information is available only to persons who have received the proper option risk disclosure documents. For a copy
of the risk disclosure documents, please contact your Broker’s Representative or visit the OCC’s website at Other Disclosures
All research reports made available to clients are simultaneously available on our client websites. Not all research content is redistributed, e-mailed or made available to third-party aggregators.
For all research reports available on a particular stock, please contact your respective broker’s sales person.
Ownership and material conflicts of interest Disclosure
Elite Wealth Limited policy prohibits its analysts, professionals reporting to analysts from owning securities of an y company in the analyst’s area of coverage. Analyst compensation: Analysts are salary based permanent employees of Elite Wealth Limited. Analyst as officer or director: Elite Wealth Limited policy prohibits its analysts, persons reporting to analysts from serving as an officer, director, advisory board member or employee of any company in the analyst’s area of coverage.
Country Specific Disclosures
India – For private circulation only, not for sale. Legal Entities Disclosures
Mr. Ravinder Parkash Seth is the Managing Director of Elite Wealth Ltd (EWL, henceforth), having its registered office at Casa Picasso, Golf Course Extension, Near Rajesh Pilot Chowk, Radha Swami, Sector-61, Gurgaon-122001 Haryana, is a SEBI registered Research Analyst and is regulated by Securities and Exchange Board of India. Telephone:011-43035555, Facsimile: 011- 22795783 and Website:
EWL Advisory discloses all material information about itself including its business activity, disciplinary history, the terms and conditions on which it offers research report, details of associates and such other information as is necessary to take an investment decision, including the following:
1. Reports
a) EWL Advisory or his associate or his relative has no financial interest in the subject company and the nature of such financial interest;
(b) EWL Advisory or its associates or relatives, have no actual/beneficial ownership of one %. or more in the securities of the subject company, at the end of the month immediately preceding the date of publication of the research report or date of the public appearance;
(c) EWL Advisory or its associate or his relative, has no other material conflict of interest at the time of publication of the research report or at the time of publicappearance;
2. Compensation
(a) EWL Advisory or its associates have not received any compensation from the subject company in the past twelve months;
(b) EWL Advisory or its associates have not managed or co-managed public offering of securities for the subject company in the past twelve months;
(c) EWL Advisory or its associates have not received any compensation for investment banking or merchant banking or brokerag e services from the subject companyin the past twelve months;
(d) EWL Advisory or its associates have not received any compensation for products or services other than investment banking or merchant banking or brokerageservices from the subject company in the past twelve months;
(e) EWL Advisory or its associates have not received any compensation or other benefits from the subject company or third party in connection with the research report. 3 In respect of Public Appearances
(a) EWL Advisory or its associates have not received any compensation from the subject company in the past twelve months;
(b) The subject company is not now or never a client during twelve months preceding the date of distribution of the research report and the types of services provided by EWL Advisory